We show how these various cellular population representations affect the vascular endothelial growth factor (VEGF) distribution throughout a whole-body model, anti-VEGF treatment efficacy, and how these representations may affect anti-VEGF treatment at different time points during tumor growth. The gene discussed is VEGFA; the disease is neoplasm.